MENU
TERN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Terns Pharmaceuticals (TERN) Ownership - Who owns Terns Pharmaceuticals?
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
1065 East Hillsdale Boulevard
Phone
+1 650 525-5535
Employees
66
Web
https://www.ternspharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
313.42M
P/E Ratio
N/A
Total Cash
372.78M
Projected Growth
N/A
Total Debt
1.31M
Revenue
N/A
Risk (Beta)
-0.70
Dividend Yield
N/A
Total Cash/Share
4.39
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TERN
Capitalization
313M
P/E Ratio
N/A
Risk (Beta)
-0.70
Dividend Yield
N/A
Total Cash
373M
Total Cash/Share
4.39
Total Debt
1.31M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
364M
P/B Ratio
0.86
Cash Flow
N/A
Earnings
-1.18
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
32.99
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-99.08M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-27.10
Shares Held By Institutions
781M
Shares Outstanding - Current
84.9M
Total Liabilities
13.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-33.393
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1065 East Hillsdale Boulevard
Phone
+1 650 525-5535
Employees
66
Web
https://www.ternspharma.com